Paylean™ and Tylan™

Veterinary medicine · U.S. Food and Drug Administration, Center for Veterinary Medicine · United States

  • Animal drug application 141172
  • Animal drug product ID 521

What the source publishes

Holder
Elanco US Inc.
Active ingredients
Ractopamine Hydrochloride Tylosin Phosphate
Form
Type A medicated articles for use in the manufacture of Type B and Type C medicated feeds
Routes
Oral
Supply regime
VFD

Names this record is found by

Complete source data
us:fda:animaldrugs:420:521
{
  "form": "Type A medicated articles for use in the manufacture of Type B and Type C medicated feeds",
  "name": "Paylean™ and Tylan™",
  "holder": "Elanco US Inc.",
  "routes": [
    "Oral"
  ],
  "smpcUrl": null,
  "marketed": null,
  "useDomain": "veterinary",
  "leafletUrl": null,
  "supplyRegime": "VFD",
  "nativeProduct": {
    "routes": [
      "Oral"
    ],
    "species": {
      "Swine:459": "Finishing"
    },
    "sortOrder": 0,
    "withdrawals": [
      "<p>No withdrawal period is required when used according to labeling.<br/></p>"
    ],
    "doseFormName": "Type A medicated articles for use in the manufacture of Type B and Type C medicated feeds",
    "applicationId": null,
    "specifications": "Type A medicated articles containing ractopamine hydrochloride (9 or 45.4 g/lb) and tylosin phosphate (10, 40, or 100 g/lb).",
    "proprietaryName": "Paylean™ and Tylan™",
    "proprietaryNameId": 521,
    "statusDescription": "VFD"
  },
  "nativeSummary": {
    "noohDate": null,
    "publishDate": "2026-02-09",
    "sponsorName": "Elanco US Inc.",
    "applicationId": 420,
    "applicationType": "N",
    "proprietaryName": "Paylean™ and Tylan™\n",
    "applicationNumber": 141172,
    "activeIngredientName": "Ractopamine Hydrochloride\nTylosin Phosphate\n",
    "applicationStatusCode": "A",
    "applicationStatusValue": null,
    "voluntaryWithdrawalDate": null
  },
  "targetSpecies": [
    {
      "code": "459",
      "label": "Swine",
      "native": {
        "key": "Swine:459",
        "population": "Finishing"
      },
      "sourceId": "us.fda.animal-drugs",
      "population": "Finishing",
      "canonicalId": "pig",
      "mappingStatus": "mapped",
      "mappingVersion": 1
    }
  ],
  "informationUrl": "https://animaldrugsatfda.fda.gov/adafda/views/#/search",
  "ingredientScope": "application-level; no product-specific composition inferred",
  "nativePublishDate": "2026-02-09",
  "sourceDisposition": "reviewed-veterinary-application-product",
  "useDomainEvidence": {
    "basis": "publisher-dataset-scope",
    "field": "sourceId",
    "value": "us.fda.animal-drugs",
    "version": 1,
    "sourceId": "us.fda.animal-drugs"
  },
  "withdrawalPeriods": [
    {
      "native": "<p>No withdrawal period is required when used according to labeling.<br/></p>",
      "status": "unparsed"
    }
  ],
  "patientEligibility": "not-assessed",
  "nativeApplicationId": 420,
  "targetSpeciesStatus": "reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "activeIngredientsText": "Ractopamine Hydrochloride\nTylosin Phosphate\n",
  "nativeApplicationType": "N",
  "applicationIngredients": [
    {
      "activeIngredientName": "Ractopamine Hydrochloride",
      "activeIngredientTolerance": "<p>The tolerances for ractopamine (marker residue) in swine are:<br/>(i) Liver (target tissue): 0.15 ppm.<br/>(ii) Muscle: 0.05 ppm.<br/></p>"
    },
    {
      "activeIngredientName": "Tylosin Phosphate",
      "activeIngredientTolerance": "<p>The tolerances for tylosin in swine are:<br/>Liver, kidney, fat, and muscle: 0.2 ppm.</p>"
    }
  ],
  "nativeApplicationNumber": 141172,
  "nativeProprietaryNameId": 521,
  "restrictionObservations": [
    {
      "indicationText": "<p>For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and control of porcine proliferative enteropathies (PPE, ileitis) associated with <i>Lawsonia intracellularis</i> in finishing swine weighing at least 150 lbs and fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter. Not for use in swine intended for breeding.</p>",
      "limitationText": "<p>Feed as the sole ration to finishing swine weighing at least 150 lbs for the last 45 to 90 lbs (group average) of weight gain prior to slaughter. Feed 100 g of tylosin per ton of complete feed for 21 days. Ractopamine hydrochloride use may increase the number of injured, lame, and/or fatigued pigs during marketing. Behavioral signs such as hyperactivity, anxiety, and aggression have been reported in pigs fed ractopamine hydrochloride. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.</p>",
      "populationText": "Swine"
    },
    {
      "indicationText": "<p>For increased rate of weight gain, improved feed efficiency, increased carcass leanness, control of swine dysentery associated with <i>Brachyspira hyodysenteriae</i>, and control of porcine proliferative enteropathies (PPE, ileitis) associated with <i>Lawsonia intracellularis</i> in finishing swine weighing at least 150 lbs and fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter. Not for use in swine intended for breeding.</p>",
      "limitationText": "<p>Feed as the sole ration to finishing swine weighing at least 150 lbs for the last 45 to 90 lbs (group average) of weight gain prior to slaughter. Feed 100 g of tylosin per ton of complete feed for at least three weeks, followed by 40 g tylosin per ton of complete feed until pigs reach market weight. Ractopamine hydrochloride use may increase the number of injured, lame, and/or fatigued pigs during marketing. Behavioral signs such as hyperactivity, anxiety, and aggression have been reported in pigs fed ractopamine hydrochloride. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.</p>",
      "populationText": "Swine"
    },
    {
      "indicationText": "<p>For increased rate of weight gain, improved feed efficiency, increased carcass leanness, the treatment and control of swine dysentery associated with <i>Brachyspira hyodysenteriae</i>, and control of porcine proliferative enteropathies (PPE, ileitis) associated with <i>Lawsonia intracellularis </i>immediately after medicating with tylosin in drinking water in finishing swine weighing at least 150 lbs and fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter. Not for use in swine intended for breeding.</p>",
      "limitationText": "<p>Feed as the sole ration to finishing swine weighing at least 150 lbs for the last 45 to 90 lbs (group average) of weight gain prior to slaughter. Feed 40 to 100 grams of tylosin per ton of complete feed for 2 to 6 weeks immediately after medicating with tylosin in drinking water (250 mg tylosin per gallon) for 3 to 10 days. Ractopamine hydrochloride use may increase the number of injured, lame, and/or fatigued pigs during marketing. Behavioral signs such as hyperactivity, anxiety, and aggression have been reported in pigs fed ractopamine hydrochloride. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.</p>",
      "populationText": "Swine"
    }
  ],
  "withdrawalPeriodsStatus": "reported-unparsed",
  "publisherIdentityMeaning": "applicationId/proprietaryNameId are technical website keys; applicationNumber is a separate FDA application reference",
  "nativeNoticeOfHearingDate": null,
  "nativeApplicationStatusCode": "A",
  "nativeVoluntaryWithdrawalDate": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.animal-drugs" \
  --data-urlencode "id=us:fda:animaldrugs:420:521"